dc.contributor.author | Aras, Yavuz | |
dc.contributor.author | Aktas, Esin | |
dc.contributor.author | Sabanci, Akin | |
dc.contributor.author | Alpman, Vehbi | |
dc.contributor.author | Bilir, Ayhan | |
dc.contributor.author | Erguven, Mine | |
dc.contributor.author | Yazihan, Nuray | |
dc.contributor.author | Ermis, Ezgi | |
dc.date.accessioned | 2021-03-05T19:24:44Z | |
dc.date.available | 2021-03-05T19:24:44Z | |
dc.identifier.citation | Erguven M., Bilir A., Yazihan N., Ermis E., Sabanci A., Aktas E., Aras Y., Alpman V., "Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine", CANCER CELL INTERNATIONAL, cilt.11, 2011 | |
dc.identifier.issn | 1475-2867 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_cf2c9204-f763-44de-9139-4bcbd6dbf35a | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/137001 | |
dc.identifier.uri | https://doi.org/10.1186/1475-2867-11-18 | |
dc.description.abstract | Background: Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imatinib mesylate (IM) on human GBM in vitro and the role of midkine (MK) in this new combination treatment. | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine | |
dc.type | Makale | |
dc.relation.journal | CANCER CELL INTERNATIONAL | |
dc.contributor.department | İstanbul Yeni Yüzyıl Üniversitesi , , | |
dc.identifier.volume | 11 | |
dc.contributor.firstauthorID | 71412 | |